Advertisement

Cefazolin Injection

[25 January 2016]

Products Affected - Description

Cefazolin powder for solution for injection, Apotex
1 gram, vial, 25 count (NDC 60505-0749-05)
10 gram, vial, 1 count (NDC 60505-0769-00)
 
Cefazolin injection, BBraun
1 gram/50 mL premix, 1 count (NDC 00264-3103-11)
2 gram/50 mL premix, 1 count (NDC 00264-3105-11)
 
Cefazolin injection, Baxter
2 gram/100 mL, premixed bag, 12 count (NDC 00338-3508-41)
 
Cefazolin powder for solution for injection, Sagent
1 gram, vial, 25 count (NDC 25021-0101-10)
10 gram, vial, 1 count (NDC 25021-0102-99)

Reason for the Shortage

  • BBraun has cefazolin on shortage due to increased demand.
  • Fresenius Kabi has cefazolin on shortage due to increased demand.
  • WG Critical Care has cefazolin on shortage due to increased demand. WG Critical Care discontinued cefazolin 20 gram to focus on other strengths.
  • Sandoz had cefazolin on shortage due to manufacturing delays.
  • Hospira has cefazolin available.
  • Sagent has cefazolin on shortage due to increased demand.

Available Products

Cefazolin injection, Baxter
1 gram/ 50 mL premix, 24 count (NDC 00338-3503-41)
 
Cefazolin powder for solution for injection, Fresenius Kabi
1 gram, vial, 25 count (NDC 63323-0237-10)
10 gram, vial, 1 count (NDC 63323-0238-61)
20 gram, vial, 1 count (NDC 63323-0446-66)
500 mg, 1 count (NDC 63323-0236-10)
 
Cefazolin powder for solution for injection, Hospira
1 gram, Add-Vantage vial, 25 count (NDC 00409-2585-01)
1 gram, vial, 25 count (NDC 00409-0805-01)
10 gram, vial, 10 count (NDC 00409-0806-01)
 
Cefazolin powder for solution for injection, Sagent
500 mg, vial, 25 count (NDC 25021-0100-10)
 
Cefazolin powder for solution for injection, Samson Medical Technologies
100 gram SmartPak bulk package (NDC 66288-1100-01)
300 gram SmartPak bulk package (NDC 66288-1300-01)
 
Cefazolin powder for solution for injection, Sandoz
1 gram, 25 count, (NDC 00781-3451-96)
10 gram, 10 count (NDC 00781-3452-95)
500 mg, 10 count (NDC 00781-3450-95)
 
Cefazolin powder for solution for injection, WG Critical Care
1 gram, 25 count (NDC 44567-0707-25)
10 gram, vial, 10 count (NDC 44567-0708-10)
500 mg, 25 count (NDC 44567-0706-25)
 
Cefazolin powder for solution for injection, West-Ward
1 gram, 25 count (NDC 00143-9924-90)
10 gram, 10 count (NDC 00143-9983-03)
500 mg, 25 count (NDC 00143-9923-90)

Estimated Resupply Dates

  • Apotex has cefazolin 1 gram and 10 gram vials on intermittent back order and the company is releasing product as it becomes available.
  • Baxter has cefazolin 2 gm/100 mL bags on allocation.
  • BBraun has cefazolin 1 gram/50 mL and 2 gram/50 mL premixes on allocation for contracted customers.
  • Sagent has cefazolin 1 gram vials on back order and the company estimates a release date of February 2016. Cefazolin 10 gram vials are available on allocation.
  • West-Ward has cefazolin 1 gram vials on weekly allocation.

Related Shortages

Updated

January 25 and 6, 2016; December 17 and 10, November 25, October 27 and 13, September 3, August 18, July 28, June 25 and 11, May 28, 21, 13 and 12, April 29, 17 and 2, March 10, February 20 and 5, January 20 and 9, 2015; December 22, 12 and 5, November 21, 20, 11 and 6, October 16 and 1, September 26, 18 and 4, August 21, July 18, June 26 and 13, May 28, 12 and 8, April 30, 15 and 2, March 25, 18 and 5, February 19 and 10, January 29, 24, 21 and 6, 2014; December 19 and 3, November 13, October 30, 21 and 10, September 23 and 3, August 27, 13 and 1, July 18 and 3, June 6, May 30 and 6, April 12 and 1, March 29 and 7, February 12 and 5, January 23 and 10, 2013, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement